What is Kalion?
Kalion specializes in the production of high-purity glucaric acid and other bio-based chemicals derived from biomass through advanced fermentation and proprietary synthetic biology techniques. Their offerings cater to diverse industrial applications, including water treatment, materials enhancement, and the pharmaceutical market. The company's focus on high-purity, bio-derived chemicals positions it as a key player in the sustainable chemical solutions sector, addressing the growing demand for environmentally conscious industrial inputs.
How much funding has Kalion raised?
Kalion has raised a total of $1.7M across 2 funding rounds:
Private Equity
$697K
Private Equity
$1M
Private Equity (2015): $697K, investors not publicly disclosed
Private Equity (2017): $1M led by Cherrystone Angel Group
Key Investors in Kalion
Cherrystone Angel Group
Cherrystone Angel Group is an investment firm focused on early-stage companies, providing capital and expertise across various sectors including life sciences and technology. They actively support portfolio companies with industry knowledge to aid in scaling.
What's next for Kalion?
With the recent influx of major strategic investment, Kalion is poised for significant expansion. The enterprise-level capital infusion is expected to accelerate the scaling of its production capabilities and broaden its market reach within the industrial, materials, and pharmaceutical sectors. This strategic backing will likely support further research and development into novel bio-based chemical applications and strengthen its competitive position against traditional chemical manufacturers. The company's trajectory suggests a focus on solidifying its market share and potentially exploring new product lines derived from its core biotechnology platform.
See full Kalion company page
